Moral complicity in induced pluripotent stem cell research
1University of Wisconsin Colleges, Wausau, USA.
Kennedy Institute of Ethics Journal
|March 25, 2009
Summary
Induced pluripotent stem cell (iPSC) technology offers an alternative to embryonic stem cells but still involves ethical considerations. Policies hindering iPSC research may cause patient harm, suggesting a need for careful ethical navigation.
Area of Science:
- Biotechnology
- Stem Cell Research
- Bioethics
Background:
- Direct reprogramming of human skin cells yields induced pluripotent stem cells (iPSCs), bypassing embryonic stem cell (ESC) destruction.
- However, iPSC research is ethically entangled due to its origins in and reliance on ESC research.
Purpose of the Study:
- To analyze the ethical implications and moral complicity associated with induced pluripotent stem cell (iPSC) research.
- To evaluate the impact of policies on iPSC research and patient welfare.
Main Methods:
- Ethical analysis of stem cell research origins and applications.
- Review of policy impacts on biotechnological advancement and patient care.
Main Results:
- iPSC technology, while avoiding direct embryo destruction, creates new forms of moral complicity.
- Policies restricting iPSC research to avoid ethical issues may inadvertently lead to patient harm.
Conclusions:
- Moral complicity in stem cell research may be unavoidable.
- A Blue Ribbon Panel assessing the need for new embryonic stem cell lines could facilitate the transition from ESC to iPSC clinical applications.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...